Compound Western medicine for treating pertussis

Abstract

The invention discloses a compound Western medicine for treating pertussis. The compound Western medicine is prepared from the following main raw materials in parts by weight: 5-15 parts of camellianin A, 3-7 parts of palmatrubine, 20-30 parts of norswertianolin, 8-12 parts of taccalonolide B, 2-4 parts of ginkgetin, 1-3 parts of isomangiferin, 10-15 parts of menthol, 23-30 parts of campesterol, 2-5 parts of 5-hydroxy-p-naphthoquinone, and 2-4 parts of sanguinarine citrate. According to the compound Western medicine, the raw materials are strictly selected according to the knowing mechanism for pertussis, so that the purpose of comprehensive rehabilitation is achieved, and in addition, the compound Western medicine has the advantages of being rapid in taking effect, stable in effect, convenient to carry and take, and free of toxic and side effects after long-term administration.

Description

technical field

[0001] The invention relates to the field of medicine preparation, in particular to a compound western medicine for treating pertussis. Background technique

[0002] Whooping cough is a common acute respiratory infectious disease in children, and Bacillus pertussis is the pathogenic bacteria of this disease. It is characterized by paroxysmal spasmodic cough, accompanied by a special inspiratory roar at the end of the cough, and the course of the disease is long, up to several weeks or even 3 months, so it is called pertussis. When infants suffer from this disease, they are prone to complications such as suffocation, pneumonia, and encephalopathy, and the fatality rate is high. In recent years, the incidence of infants and adults has increased, and 40% of the fatal cases are infants and young children within 5 months. Early treatment with antibiotics generally leads to a good prognosis. The disease spreads all over the world, is generally sporadic, and can ...